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CC BY-NC-ND license (http://creativAbstract Background: Choosing a breast reconstructive modality after mastectomy is a crit-
ical step involving complex decisions. Postoperative complications can be a significant setback
for patients undergoing breast reconstruction. In this study, the results of different reconstruc-
tive modalities are recorded and their complications are discussed for further preoperative
counseling.
Materials and Methods: Ninety patients who had undergone breast reconstruction at our insti-
tution in the past 5 years were reviewed. Clinical encounters for all reconstruction modalities,
namely implant-based, autologous tissue, and combined reconstructions, were assessed. We
evaluated several clinical variables, such as type of operation, timing of reconstruction, and
early and late complications.
Results: Patients were aged 28e61 years, with a mean age of 44.8 years. The body mass index
(BMI) ranged from 16.9 to 31.1 kg/m2, with an average of 22.87 kg/m2. The follow-up duration
ranged from 5.6 to 85.9 months, with a mean of 38.3. Thirty-eight, 46, and 6 patients received
implant-based reconstruction, autologous reconstruction, and combined reconstruction,
respectively. The most common complication recorded in the implant-based group was hema-
toma (7.9%), whereas re-exploration (6.5%) and abdominal hernia (6.5%) were the most com-
mon complications in the autologous tissue reconstruction group. The average age and BMI of
the patients who experienced complications were 46.4 years and 22.5 kg/m2, respectively,
whereas the average age and BMI for the patients without complications were 44 years and
23 kg/m2, respectively. Complications were most common in patients who underwent adjuvant
irradiation and pedicle flap reconstruction (100%).uthors have a financial interest in any of the products, devices, or drugs mentioned in this article.
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Immediate (n Z 66) 3
Delay (n Z 24) 8
Types of reconstruction T
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BMI Z body mass index; DIEP Z dee
rectus abdominis myocutaneous.Conclusion: In this small-scale study, we found that an implant-based reconstruction was more
frequently performed on older patients. Because of the relatively small average body size and
low BMIs of Asian people, obesity is not considered to affect the postoperative complication
rate. In addition, postreconstructive irradiation is unlikely to produce additional complications
because the patients underwent pedicle flap reconstruction.
Copyright ª 2016, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Breast cancer is one of the most common cancers among
women worldwide.1 Postmastectomy breast reconstruction
is currently widely used for oncological safety2e4 and
because of its higher psychosocial satisfaction.5 Breast
cancer is generally treated using multimodalities, including
surgical resection, hormone therapy, chemotherapy, and
radiation. In addition, various postmastectomy recon-
structive methods, such as implant-based, autologous tis-
sue, or combined reconstructions, are available.6 Each of
these reconstructive methods has its own benefits and
drawbacks.7 An implant-based reconstruction may provide
short surgical and hospitalization time but generates rela-
tively long periods of postoperative complications. By
contrast, an autologous tissue reconstruction results in a
more durable appearance and a relatively short complica-
tion phase; however, it requires long surgical and hospi-
talization time. By contrast, a combination of the
autologous tissue and implant-based reconstructions is an
effective compromise because one method can comple-
ment the other.
For patients, one of the key satisfaction predictors is the
postoperative complication rate.8 Furthermore, post-
operative complications are a considerable setback for
patients undergoing breast reconstruction. Therefore,
choosing an appropriate reconstructive modality for each
individual is a critical step that involves complex consid-
erations. Within the limited scale of this study, the com-
plications arising after the three most common
reconstructive modalities are compared to aid preoperative
counseling and discussion.ypes, and timing of breast reco






p inferior epigastric perforator;2. Materials and methods
All 90 patients who underwent breast reconstruction at our
institution during the past 5 years were reviewed. The
clinical encounters of all reconstruction modalities were
assessed, which included 38, 46, and 6 patients who un-
derwent implant-based, autologous tissue, and combined
reconstructions, respectively. Implant-based reconstruc-
tion involved prosthesis and tissue expander placement.
The flaps of the autologous reconstruction group included a
free deep inferior epigastric perforator (DIEP), free supe-
rior gluteal artery (SGA), free transverse rectus abdominis
myocutaneous (TRAM), and pedicled-TRAM flaps. The
combined reconstruction group solely used the latissimus
dorsi (LD) flap with an implant placement (Table 1). Several
clinical variables, including patients’ type of surgery, time
required for the reconstruction, and early and late com-
plications, were reviewed in this study. We defined early
and late complications as those that occurred within and
after 3 weeks of the surgery, respectively.
The Chi-square test was used for comparing the statis-
tical differences among the different groups. A value of
p < 0.05 was considered statistically significant, and all
confidence intervals were reported within the range of 95%.
All calculations were performed using SPSS for Windows,
Version 21.0 (Chicago, IL, USA).3. Results
All patients were aged 28e61 years (mean, 44.8 years). The
mean ages of the implant-based, autologous tissue (38 freenstructions in our study patients.






Pedicled TRAM flap (8)
Free TRAM flap (16)
Free DIEP flap (17)
Superior gluteal artery flap (2)
LD flap þ implant (6)
LD Z latissimus dorsi; TE Z tissue expander; TRAM Z transverse




















DIEP Z deep inferior epigastric perforator; LD Z latissimus
dorsi; TE Z tissue expander; TRAM Z transverse rectus
abdominis myocutaneous.
Breast reconstruction following mastectomy 11flaps and 8 pedicled-TRAM flaps), and combined recon-
struction groups were 47.8, 42.5, and 42.2 years, respec-
tively. The body mass index (BMI) ranged from 16.9 to
31.1 kg/m2 (mean, 22.87 kg/m2). The three groups had
mean BMIs of 22.35, 23.45, and 20.62 kg/m2, respectively
(Table 1). Among these patients, 66 received immediate
reconstruction (73.3%) and 24 received a delayed recon-
struction (26.7%). In addition, 16 patientsd7 patients from
the implant-based, 8 from the autologous tissue, and 1 from
the combined groupsdreceived irradiation for adjuvant
therapy (Table 2).
Postoperative complications were divided into early and
late complications for each reconstruction group. In the
autologous tissue reconstruction group, all the flaps sur-
vived, except for one partial flap loss. We noticed that the
autologous reconstruction group had the highest total
complication rate (18/46, 39.1%) compared with those of
the implant-based and combination reconstruction groups
(29% and 33.3%, respectively) with no significant differenceTable 3 Complications after various breast reconstruction met
Implant-based Autologous
Implant (25) TE (13) LD (3) p-TRA
Early
Hematoma 3 - - -
Infection - - - 1
Wound dehiscence 1 - - 1
Fat necrosis - - - 1
Reopen - - - -
Flap total loss - - - -
Flap partial loss - - - 1
Seroma 1 1 1 -
Late
Abdominal hernia - - - 1
Scar - 1 - 2
Malposition 1 1 - -
Capsule contracture 1 1 - -
DIEP Z deep inferior epigastric perforator; f-TRAM Z Free TRAM; LD
gluteal artery; TE Z tissue expander.(p Z 0.268). The most common early complications in the
implant-based and autologous tissue groups were hema-
toma (3/38, 7.9%) and re-exploration (3/46, 6.5%),
respectively. The most common late complications in the
implant-based reconstruction group were malposition (2/
38, 5.3%) and capsular contracture (2/38, 5.3%). Abdominal
hernia (3/46, 6.5%) only occurred in the autologous tissue
reconstruction group involving two free DIEP flaps and one
pedicled-TRAM flap (Table 3).
The average age and BMI of the patients experiencing
complications were 46.4 years and 22.5 kg/m2, respec-
tively, whereas those for patients without complications
were 44 years and 23 kg/m2, respectively. For patients who
underwent immediate reconstruction, the complication
rate was 33.3% (22/66), whereas it was 37.5% (9/24) for
patients who underwent delayed reconstruction.
In the autologous tissue reconstruction group, six pa-
tients who received adjuvant irradiation and underwent
free flap reconstruction showed no complications. By
contrast, 9 of the 29 patients (31%) who did not undergo
irradiation experienced complications. Among the patients
undergoing a pedicle flap (one LD and one pedicled-TRAM
flap) reconstruction, two patients receiving adjuvant irra-
diation (100%) showed complications of seroma and wound
dehiscence. Among four patients receiving adjuvant irra-
diation and an implant-based reconstruction, one patient
experienced dehiscence, whereas no complications were
observed in three patients undergoing adjuvant irradiation
and tissue expander reconstruction. One patient in the
combined reconstruction group undergoing irradiation
experienced partial flap necrosis and required de`bridement
and wound closure.
A higher complication rate was observed in patients with
pedicle flap reconstructions (LD and pedicled-TRAM; 72.7%,
8/11) than in those receiving free flap reconstructions (free
TRAM, DIEP, and SGA; 28.6%, 10/35). Furthermore, the
complication rate further reduced to 54.5% in patients withhods.
Combination
M (8) f-TRAM (16) DIEP (17) SGA (2) LD þ Implant (6)
- - - 1
- 1 - -
- - - -
1 - - -
1 1 1 -
- - - -
- - - 1
- - - -
- 2 - -
1 2 - -
- - - -
- - - -
Z latissimus dorsi; p-TRAM Z pedicled TRAM; SGA Z superior
12 Y.-J. Tsai et al.pedicle flap reconstruction (6/11), but the rate was higher
than that observed for those with free flap reconstruction.
After breast reconstructions, 8.9% of the patients un-
derwent secondary procedures, including scar revision and
release contracture (Table 4).4. Discussion
Breast cancer is a neoplasm that is being seen more often in
female patients. To meet the rising demand for enhanced
aesthetic appearance, breast reconstruction has been
widely performed after mastectomy for boosting the self-
confidence and quality of life in many female patients.9
Various reconstructive methods have their own contrain-
dications, advantages, and disadvantages.7 Implant-based
reconstruction is associated with a short surgical and hos-
pitalization time without donor site morbidity; however,
there is the risk of capsular contracture and implant
malposition.10,11 By contrast, autologous tissue recon-
struction has a long surgical and hospitalization time with
risks of flap failure, donor site morbidity, and scar forma-
tion; however, it provides a more natural appearance and
efficient protection from irradiation.12e14 Combined
reconstruction can provide a neutral balance between the
implant-based and autologous tissue reconstruction
methods.15 Because of the presence of multiple recon-
structive modalities and cofactors, balancing patient safety
and expectation is difficult.16 Therefore, preoperative dis-
cussions among plastic surgeons, general surgeons, and
patients are essential before a patient begins the process of
breast reconstruction. The preoperative issues are dis-
cussed herein.
4.1. Age
Age is one of the most crucial factors influencing patients’
desire to undergo breast reconstruction after mastec-
tomy.17 Furthermore, because of the higher probability of
comorbidities among older patients, a less time-intensive
and simple reconstruction method is preferred.18,19 This
surgical strategy is consistent with our surgical strategies.
Although the mean age of the patients in the implant-based
reconstruction group (47.8 years) was higher than that of
patients in the other two groups (42.2 and 42.5 years in
autologous tissue and combined reconstruction groups,
respectively), the differences among the groups were










Scar revision 1 5 - 6.7%
Release
contracture
2 - - 2.2%
Redo flap - - - 0%
Total 7.9% 10.9% 0% 8.9%vs. combined, p Z 0.808; autologous vs. combined,
p Z 0.720).
The average age of patients experiencing complications
was 46.4 years, whereas that of patients without compli-
cations was 44 years, with no major statistical difference
(p Z 0.066) between the two groups.
4.2. Body mass index
The World Health Organization (WHO) defines individuals
with BMI > 25 kg/m2 as overweight and those with
BMI > 30 kg/m2 as obese. According to the WHO grading
system, Asian people have a relatively small body size;
therefore, the BMI values are modified. For Asians,
BMI> 23 kg/m2 is considered overweight and BMI> 25 kg/
m2 is considered obese. Furthermore, the Taiwan Ministry
of Health classifies BMI> 24 kg/m2 as overweight and
BMI> 27 kg/m2 as obese. Obesity is one of the main risk
factors for postmastectomy reconstruction complications
irrespective of the reconstruction method employed.20,21 In
this study, we observed that the average BMI of patients
experiencing complications was 22.5 kg/m2, whereas that
of patients without complications was only 23, with no
significant difference (p Z 0.519). This result may relate
well with the Asian population who have a relatively small
body weight; this was true for our patients, 11 of whom
were obese and 16 overweight.
4.3. Timing
An immediate postmastectomy breast reconstruction not
only ensures oncological safety and a single-stage recon-
struction but also yields a more satisfied body image,
femininity, and sexuality.22 In our study, most patients (66/
90, 73.3%) underwent immediate reconstruction after
mastectomy. By contrast, delayed breast reconstruction is
optimal for patients with more advanced breast cancers
who are at a high risk of recurrence and requiring adjuvant
therapies, specifically irradiation.23 Accordingly, only
26.7% of our patients received delayed reconstructions.
Patients who underwent immediate reconstruction
exhibited a lower complication rate (33.3%) than that
observed among those who underwent delayed recon-
struction (37.5%), with no significant difference
(p Z 0.461). Although immediate reconstructions are
beneficial, we believe that patients’ preferences, adju-
vant chemotherapy, and irradiation are essential aspects
that must be considered before deciding on the timing of
the reconstructive surgery.
4.4. Individual complication rate
Studies have reported complication rates of implant-based,
autologous tissue, and combined reconstruction groups as
5.8e49%, 22.6e44.3%, and 29.8%, respectively.24,25 Our
results are consistent with these findings; the complication
rate of the autologous tissue reconstruction group (36.9%)
was higher than that of the implant-based (29%) and com-
bined (33.3%) reconstruction groups. However, the differ-
ences among the groups were nonsignificant.
Breast reconstruction following mastectomy 134.5. Radiotherapy
Radiation treatment is commonly considered a risk factor
for postoperative complications in breast reconstructions
after mastectomy; both postoperative ablation and antici-
pated irradiation have the same effects.26,27 In our series,
of the 16 patients receiving adjuvant radiotherapy, 4 pa-
tients showed complications: 2 patients with pedicled-
TRAM and implant-based reconstructions experienced
wound dehiscence, 1 patient with an LD reconstruction
experienced seroma, and 1 patient with a combined
reconstruction experienced a partial flap loss. Patients who
underwent radiotherapy had an early complication rate of
25% (4/16), whereas those who did not undergo radio-
therapy had comparable early and late complication rates
of 18.9% (14/74) and 17.6% (13/74), respectively (Table 5).
The differences in radiotherapy affecting early (pZ 0.586)
and late (p Z 0.81) complications between the two groups
were nonsignificant. By isolating the effect of radiation, the
complication rates for implant-based, autologous tissue,
and combined reconstruction were 27%, 36.4%, and 20%,
respectively, but with no significant differences (implant
vs. autologous, p Z 0.325; implant vs. combined,
p Z 0.979; autologous vs. combined, p Z 0.635). Never-
theless, radiotherapy after a reconstructive surgery in-
creases the prospect of postoperative early
complications28; this is consistent with our finding that 25%
of patients receiving adjuvant radiotherapy experienced
early complications; however, only 18.9% of the patients
without radiotherapy experienced early complications.
4.6. Free flap or pedicle flap
Differences between the complications arising from the
pedicle flap (pedicled-TRAM and LD) and free flap re-
constructions, such as free TRAM, free DIEP, free SGA, and
free LD, have been extensively studied.29 Although fat and
flap necrosis appear more in patients who underwent
pedicled-TRAM reconstruction, an increasing number of
reconstructive surgeons believe that no substantial evi-
dence differentiating the pedicled-TRAM from the free flap
reconstruction method has been reported.30 Among the
limited number of cases observed in our study, the patients
who underwent pedicle flap reconstruction had a signifi-
cantly higher (pZ 0.04) complication rate (72.7%) than did
those who underwent free flap reconstruction (28.6%).
After isolating the effect of irradiation, the complication
rate in patients who underwent pedicle flap reconstruction
was 54.5%. We speculate that a study involving analysis of
variance will yield similar results regarding the effects of






Early complications 4 14
Late complications 0 13Because of the limited number of patients in this study,
justifying all our findings is not feasible; however, we
clarified related postmastectomy breast recon-
structionerelated topics by referring to relevant literature.
The results of this study serve as reference for patient-
edoctor preoperative counseling; however, additional
studies are necessary.
5. Conclusion
Implant-based reconstruction appears to be the most
preferable option for older patients after mastectomy.
Because of the relatively small body size and BMIs among
Asian patients, obesity may not be influential in the
development of postoperative complications. Although
immediate reconstruction may provide oncological safety
and psychosocial comfort, delayed reconstruction is still
the preferred choice for patients, specifically for those at
high risk of local recurrence or metastasis. Adjuvant radi-
ation therapy can lead to complications after breast
reconstruction; however, the high influence of radiotherapy
on the complication rate of patients receiving pedicle flap
reconstruction remains unclear.
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